| Value | Category | Cases | |
|---|---|---|---|
| ALUVIA and | 1 |
0.3%
|
|
| ART | 16 |
5.5%
|
|
| ARV s | 1 |
0.3%
|
|
| ARVS | 3 |
1%
|
|
| ARVs | 72 |
24.7%
|
|
| Aldomet 25 | 1 |
0.3%
|
|
| Anti Tb dr | 1 |
0.3%
|
|
| Antihypert | 1 |
0.3%
|
|
| Antiretrov | 2 |
0.7%
|
|
| Arvs | 2 |
0.7%
|
|
| Asthavent | 1 |
0.3%
|
|
| Completed | 1 |
0.3%
|
|
| Epillim 20 | 1 |
0.3%
|
|
| FDC | 19 |
6.5%
|
|
| FDC 2011 S | 1 |
0.3%
|
|
| FDC [EFAVU | 1 |
0.3%
|
|
| FdC [efavu | 1 |
0.3%
|
|
| HAART | 88 |
30.1%
|
|
| HAART (FDC | 1 |
0.3%
|
|
| HCT | 1 |
0.3%
|
|
| HCT 12.5 m | 1 |
0.3%
|
|
| HHART | 1 |
0.3%
|
|
| Haart | 1 |
0.3%
|
|
| Haart (201 | 1 |
0.3%
|
|
| Iron suppl | 1 |
0.3%
|
|
| Largactil | 1 |
0.3%
|
|
| Lifelong A | 1 |
0.3%
|
|
| Not indica | 1 |
0.3%
|
|
| On AART + | 1 |
0.3%
|
|
| On ART | 4 |
1.4%
|
|
| On ARVs | 1 |
0.3%
|
|
| On FDC | 2 |
0.7%
|
|
| On HAART | 3 |
1%
|
|
| On HPT Rx | 1 |
0.3%
|
|
| On epilept | 1 |
0.3%
|
|
| Phenobabit | 1 |
0.3%
|
|
| RVD reacti | 1 |
0.3%
|
|
| TB Rx | 1 |
0.3%
|
|
| TB TREATME | 1 |
0.3%
|
|
| TB drugs | 2 |
0.7%
|
|
| TB treatme | 1 |
0.3%
|
|
| Was on Met | 1 |
0.3%
|
|
| Yes on Art | 1 |
0.3%
|
|
| anti TB dr | 1 |
0.3%
|
|
| anti TB me | 1 |
0.3%
|
|
| anti tb dr | 1 |
0.3%
|
|
| art | 8 |
2.7%
|
|
| arvs | 9 |
3.1%
|
|
| asthavent, | 1 |
0.3%
|
|
| enalapril | 1 |
0.3%
|
|
| fdc | 1 |
0.3%
|
|
| haart | 4 |
1.4%
|
|
| hydrochlor | 1 |
0.3%
|
|
| is on MDR | 1 |
0.3%
|
|
| known RVD | 1 |
0.3%
|
|
| metformin | 2 |
0.7%
|
|
| not record | 6 |
2.1%
|
|
| on ART | 4 |
1.4%
|
|
| on HAART | 1 |
0.3%
|
|
| on Haart s | 1 |
0.3%
|
|
| unknown | 3 |
1%
|